Sleep Apnea and Diagnostic Devices Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Includes: Sleep Management Devices by Type (Therapeutic Obstructive, Sleep Apnea, and Sleep Diagnostic Devices)
発行: iData Research Inc.
世界の閉塞型睡眠時無呼吸症候群治療装置市場のシェアは、ResMed、Philips Healthcare、Fisher &Paykelが占めています。同様に、世界の睡眠診断装置市場のリーダーは、Philips Healthcare、Natus、Compumedicsとなっています。当レポートでは、世界の閉塞型睡眠時無呼吸症候群治療装置と睡眠診断機器市場について調査し、市場の概要とともに、2027年までの市場予測、市場成長の促進要因と抑制要因、および市場に参入する企業の競合情勢などを提供しています。
Throughout this medical market research, the publisher analyzed therapeutic obstructive sleep apnea device and sleep diagnostic device companies across more than 70 countries and used their comprehensive methodology to understand the Market Sizes, Unit Sold, Average Selling Prices, Company Market Shares, and to create Accurate Forecasts.
The global therapeutic obstructive sleep apnea device and sleep diagnostic device market sizes are estimated to increase over the forecast period to reach $4.9 billion and $455.1 million, respectively, by 2027.
The majority of the global therapeutic obstructive sleep apnea device market share was controlled by ResMed, Philips Healthcare, and Fisher & Paykel. Similarly, the global sleep diagnostic device market leaders were Philips Healthcare, Natus, and Compumedics.
This global market research spans over 70 countries and includes the global market for obstructive sleep apnea with the positive airway pressure device market and the sleep therapy interface market. In addition, the sleep diagnostic devices market is included with the polysomnography device market and the home respiratory polygraph device market.
The primary driver for therapeutic obstructive sleep apnea devices in many markets is the growing awareness among the general population of sleep apnea symptoms and the benefits of its treatment. COVID-19 did not contribute to an increase in sleep-related conditions but, rather, sleep apnea therapy devices are less complex and easier to assemble than ventilators. In cases of severe COVID-19 where patients require acute care, and also in some home care applications, sleep therapy devices can be used in place of ventilators, contributing to a short-term rise in demand.
The total sleep diagnostic device market is expected to grow steadily throughout the forecast period. Dictating a considerable price point are the polysomnography devices, which are by far the most sophisticated and accurate tests in the market. The ease of use and lower price point of home respiratory polygraphy devices will result in the market's notable future growth. In certain cases of COVID-19 where patients require acute care, and also in some home care applications, sleep apnea diagnostic devices can be used in place of ventilators, contributing to a short-term rise in demand.
ResMed, Philips Healthcare, and Fisher & Paykel controlled the global therapeutic obstructive sleep apnea device market share. The global sleep diagnostic device market was led by Philips Healthcare, Natus, and Compumedics.
In 2020, ResMed was the leading competitor in the therapeutic obstructive sleep apnea device market, with a notable presence in both the sleep therapy interface and PAP device segments. Philips Healthcare was the leading competitor in the sleep diagnostic device market, with a notable presence in both the polysomnography device and home respiratory polygraphy device segments.
Throughout this report, iData Research has covered over 70 countries across the globe in great detail. The regions covered are: